Benzonatate
Product Images NDC 70934-055

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 70934-055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

70934 055 30 Rev B 10 19 1

70934 055 30   Rev B 10 19 1
Benzonatate Capsules, USP 200mg packaging label presenting 30 capsules per bottle. The label shows NDC 70934-055-30 and includes storage instructions, cautionary statements, and a note that the product is Rx only. The labeler is Denton Pharma, Inc. DBA Northwind Pharmaceuticals. Additional lot, manufacturing, and expiration details are visible on the right side for different NDC variations.*
FDA Label Image

Benzonatate_chem_structure.jpg (Structure)

Benzonatate_chem_structure.jpg (Structure)
Chemical structure diagram of Benzonatate, showing its molecular composition and arrangement of atoms. The formula C30H53NO11 is displayed below the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.